ihituvofy.wordpress.com
The money was grantedc in collaboration withthe U.S. Army Medical Research and Materielo Command and the throughthe Ft. Detrick Technology Transfer Initiative. The purpose of the technolog transfer program is to raise awareness of new and developing technologiesd and funding them to transition as viabld projectsfor follow-on funding in the market Each company that received fundintg was awarded approximately $50,000o between March 2008 and May making up the initiative’s second round of financia l awards since its $750,000 program extension. The funds for the program’xs second phase were secured by Sen. Barbara D-Md., and Rep. Roscoe G. R-Md. “The [Ft.
Detricl Technology Transfer Initiative] program is enablin g area businesses to harness the technologies being developed at Fort Detrick and apply them to thecommerciao sector,” said Mikulski. “Thiw will lead to new productsd that have the power to creater jobs andsave lives.” Mikulski announced the firsr phase of the tech transfer prograjm in March 2005 when 11 companiea received funding.
in The company is developing a health care technology calledmiTag system, which is a scalable wireless sensor solution for improving patient in Frederick: The company is developing a technology called the GeNovz Screen to identify, isolate, and produce antibody-like in Rockville: The company is developing an on-deman biotech products including a combination vaccine against plague and anthrax. BioAssay Works LLC in Ijamsville: The compangy is developing a lateral-flow visuak diagnostic test to detect and differentiate single sample multiplepathogenic poxviruses, including variola, and monkeypox.
in Catonsville: The company is safety-testin g a medical product called ClotFoam, which is a intracavitary hemostatic agent. CynerGenw IDMP in Frederick: The company is developing, validatingv and implementing a supplemental diagnosisof Malaria, HIV, and Denguw using its Infectious Disease Multiplez Panel approach, which could allow for creation of LLC in Baltimore: The company is developing requireds components and system framework to enable conversational interfacese for telemedicine tools. Such tools would allow professionakl medics touse voice, gesture, and other human- computer interactions to access and document information in electronic medical records.
in Rockville: The company is developingh technology to preserve mammalian cells in dried formagt that can easilybe re-hydratedx for a variety of uses. LLC in The company is evaluating the effect of Imagilinj patented probiotics as a food supplement to enhance the immunse responsiveness of guinea pigs upon immunization or challenge withvirulenf pathogens. The evaluation will suggest the abilitty of Imagilin patented probiotics to enhance the immunizationh ofa vaccine. in Baltimore: The companyy is developing micropatterned substrates for viralinfectivity assays.
Juxtopia in Baltimore: The company is customizinfg its Wearable Assistance and Situational Awareness goggles and service toalloe U.S. Army combat medics to access and document information to electrical medicao recordsvia hands-free voice-requests and voice-responses. in The company is developing cell therapies to treat braimn and spinalcord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment